VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $290,670 | -21.7% | 10,142 | -34.1% | 0.08% | -20.0% |
| Q3 2022 | $371,000 | -61.8% | 15,399 | -56.6% | 0.10% | -62.6% |
| Q2 2022 | $971,000 | -29.2% | 35,449 | -0.9% | 0.28% | -7.6% |
| Q1 2022 | $1,372,000 | +16.0% | 35,775 | -3.1% | 0.30% | +27.2% |
| Q4 2021 | $1,183,000 | +8.7% | 36,919 | 0.0% | 0.24% | +1.3% |
| Q3 2021 | $1,088,000 | -15.1% | 36,919 | -2.1% | 0.24% | -11.9% |
| Q2 2021 | $1,282,000 | -25.1% | 37,719 | -28.4% | 0.27% | -29.7% |
| Q1 2021 | $1,712,000 | -23.3% | 52,675 | -14.9% | 0.38% | -30.0% |
| Q4 2020 | $2,231,000 | -8.5% | 61,925 | -0.6% | 0.54% | -3.4% |
| Q3 2020 | $2,439,000 | +13.8% | 62,280 | +6.6% | 0.56% | +0.7% |
| Q2 2020 | $2,143,000 | – | 58,430 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |